title: Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene.
abstract: High PAI-1 levels post acute myocardial infarction (AMI) are associated with a poor outcome. Concentrations of insulin-like molecules, proinflammatory cytokines and an insertion (5G)/deletion (4G) polymorphism in the promoter of the PAI-1 gene, all influence circulating PAI-1 levels. We studied the determinants of PAI-1 in 123 patients immediately following and at 6 months after AMI. Within 24 h of AMI, PAI-1 levels were related to those of proinsulin-like molecules but not to levels of cytokines (interleukin-1beta, interleukin-6 or tumour necrosis factor-alpha), to genotype, or to interactions between genotype and cytokine concentration. PAI-1 levels 6 months after AMI were related to concentrations of interleukin-1beta but not to genotype. We have found no evidence that subjects with the 4G/4G polymorphism have higher PAI-1 levels on admission or 6 months after AMI. In these patients, levels of PAI-1 are related to concentrations of proinsulin-like molecules and of proinflammatory cytokines.
authors.affiliation: Department of Medicine, Royal Free and University College Medical School, Holborn Union Building, Archway Campus, Archway Road, Highgate Hill, London N19 3UA, UK.
authors.forename: Arshia
authors.initials: A
authors.lastname: Panahloo
authors.forename: Vidya
authors.initials: V
authors.lastname: Mohamed-Ali
authors.forename: Rosaire P
authors.initials: RP
authors.lastname: Gray
authors.forename: Steve E
authors.initials: SE
authors.lastname: Humphries
authors.forename: John S
authors.initials: JS
authors.lastname: Yudkin
mesh_terms: D000209:Acute-Phase Proteins / Q000378:metabolism*; D000368:Aged; D005260:Female; D005342:Fibrinolysis; D005500:Follow-Up Studies; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000235:genetics; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood* / Q000235:genetics*; D011110:Polymorphism, Genetic; D011384:Proinsulin / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D000209:Acute-Phase Proteins; D015850:Interleukin-6; D017395:Plasminogen Activator Inhibitor 1; D014409:Tumor Necrosis Factor-alpha; D011384:Proinsulin